CGM Intervention in Teens and Young Adults With Type 1 Diabetes (T1D)

PHASE3CompletedINTERVENTIONAL
Enrollment

153

Participants

Timeline

Start Date

January 25, 2018

Primary Completion Date

May 8, 2019

Study Completion Date

November 7, 2019

Conditions
Type 1 Diabetes Mellitus
Interventions
DEVICE

Continuous Glucose Monitor (CGM)

Participants randomized to the CGM Group will receive a Dexcom CGM device and be instructed on how to utilize the CGM data in real time for diabetes management.

Trial Locations (14)

10032

Naomi Berrie Diabetes Center at Columbia University, New York

13210

SUNY Upstate Medical University, Syracuse

19104

Children's Hospital of Philadelphia, Philadelphia

27713

University of North Carolina, Chapel Hill

37212

Vanderbilt University, Nashville

55416

IDC at Park Nicollet, Saint Louis Park

64111

Children's Mercy Hospital, Kansas City

77030

Baylor College of Medicine, Houston

80045

Barbara Davis Center--University of Colorado, Aurora

83404

Rocky Mountain Diabetes & Osteoporosis Center, Idaho Falls

90027

Children's Hospital Los Angeles, Los Angeles

94304

Stanford University, Palo Alto

06511

Yale University, New Haven

02215

Joslin Diabetes Center, Boston

All Listed Sponsors
collaborator

The Leona M. and Harry B. Helmsley Charitable Trust

OTHER

lead

Jaeb Center for Health Research

OTHER